To compare the effictiveness of topical Crisaborole 2% ointment vs topical Tacrolimus 0.1% ointment in Atopic Dermatitis

Comparative efficacy of topical Crisaborole 2% ointment vs topical Tacrolimus 0.1% ointment in mild to moderate Atopic Dermatitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084122

Enrollment

Registered

2025-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified Health Condition 2: L208- Other atopic dermatitis

Interventions

Intervention1: Crisaborole 2%: The patients will be given topical crisaborole 2% ointment for 3 months twice a day and follow up would be done at the interval of 3 weeks for 3 months. At each follow

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed case of mild to moderate atopic dermatitis who have not been treated systemically or topically ,within last 4weeks

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Improvement in SCORAD indexTimepoint: at every 3 weeks interval for 3 months	—

Secondary

Measure	Time frame
any side effectsTimepoint: at every 3 weeks interval for 3 months	—

Countries

India

Contacts

Public ContactDr Amarbir Singh Boparai

Guru Gobind Singh Medical college and hospital Faridkot

amarbirboparai@yahoo.com9815450502

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026